What Does Brixadi Treat? Understanding Its Role in Opioid Use Disorder
•
4 min read
In May 2023, the U.S. Food and Drug Administration (FDA) granted approval for Brixadi as a treatment for moderate to severe opioid use disorder (OUD). This long-acting, injectable buprenorphine is part of a comprehensive treatment plan to help patients manage cravings and withdrawal symptoms, providing a crucial answer to the question of **what does Brixadi treat**.
